Lv1
30 积分 2023-07-13 加入
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
29天前
已完结
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab
4个月前
已完结
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
4个月前
已完结
COVID‐19 infection in patients with haematological malignancies: A single‐centre survey in the latest Omicron wave in China
5个月前
已完结
Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study
6个月前
已完结
The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China
6个月前
已完结
Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children
6个月前
已完结
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allografts
8个月前
已完结
Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy
1年前
已完结
Not Every ST-Segment Elevation Is a STEMI
1年前
已完结
皖公网安备34019202002308
